ALGAE4IBD
Project Info
- Name: ALGAE4IBD – from nature to bedside – algae based bio compound for prevention and treatment of inflammation, pain and IBD
- Registration Number: N° 101000501, H2020-FNR-2020-2
- Grant Provider: EU HORIZON 2020
- Period: 2021 - 2025
- Total Subsidity (€): 271 996,00
Project Partners
- Migal Galilee Research Institute Ltd (Dr. Dorit Avni, coordinator)
- Institute of Microbiology, CAS (RNDr. Pavel Hrouzek, Ph.D)
Project leader for MBÚ AV ČR Třeboň
Project Description
Inflammatory bowel disease (IBD), including the Crohn´s disease, is one of the most important civilization disorder nowadays. Algae4IBD’s mission is to discover algal and cyanobacterial bioactive compounds reducing the inflammatory response and simultaneously silencing other IBD symptoms. The biomass of algal strains producing such compound will be used for preparation of functional food used in treatment and prevention of IBD. International consortium led by Israeli colleagues includes scientist from 21 European institutions with different expertise ranging from natural product chemistry, pharmacology, drug administration to functional food preparation.
https://cordis.europa.eu/project/id/101000501